Skip to main content

Table 4 Effect of tamsulosin plus solifenacin on group B

From: The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia

P-value

After (mean ± SD)

Before (mean ± SD)

 

< 0.001

1.29 ± 0.498

4.37 ± 0.485

(1) Quality of life

< 0.001*

5.00 ± 1.064

11.43 ± 1.458

(2) OABSS

  1. Asterisk represents significant difference between both groups: P value < 0.05 was considered statistically significant